Human semen enhancer of viral infection peptides (SEVI) and their use

US8299031B2 · kind B2 · utility

Assignee

• Viro Pharmaceuticals GmbH & Co. KG · DE

Inventors

• Ludger Ständker · Hannover, DE
• Wolf-Georg Forssmann · Hannover, DE
• Knut Adermann · Hannover, DE
• Jan Münch · Erlangen, DE
• Frank Kirchhoff · Aachen, DE
• Elke Rücker · Dresden, DE

Key dates

• Filing date: Jan 25, 2007
• Grant date: Oct 30, 2012
• Expiry date: Jul 30, 2027

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12N2740/16011
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Subject of the invention are peptides corresponding to a fragment of amino acids 240-290 of human prostatic acid phosphatase. The invention also relates to nucleic acids, antibodies, medicaments and diagnostics and their use and use of the peptides for the treatment and diagnosis of viral diseases, especially HIV disease.